Literature DB >> 25017472

HSPA5 is an essential host factor for Ebola virus infection.

St Patrick Reid1, Amy C Shurtleff1, Julie A Costantino1, Sarah R Tritsch1, Cary Retterer1, Kevin B Spurgers1, Sina Bavari2.   

Abstract

Development of novel strategies targeting the highly virulent ebolaviruses is urgently required. A proteomic study identified the ER chaperone HSPA5 as an ebolavirus-associated host protein. Here, we show using the HSPA5 inhibitor (-)- epigallocatechin gallate (EGCG) that the chaperone is essential for virus infection, thereby demonstrating a functional significance for the association. Furthermore, in vitro and in vivo gene targeting impaired viral replication and protected animals in a lethal infection model. These findings demonstrate that HSPA5 is vital for replication and can serve as a viable target for the design of host-based countermeasures. Published by Elsevier B.V.

Entities:  

Keywords:  Antiviral; Ebolavirus; HSPA5

Mesh:

Substances:

Year:  2014        PMID: 25017472     DOI: 10.1016/j.antiviral.2014.07.004

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  41 in total

1.  HSPA5/Dna K may be a useful target for human disease therapies.

Authors:  Laurence Booth; Jane L Roberts; Paul Dent
Journal:  DNA Cell Biol       Date:  2015-03       Impact factor: 3.311

2.  GRP78/BiP/HSPA5/Dna K is a universal therapeutic target for human disease.

Authors:  Laurence Booth; Jane L Roberts; Devin R Cash; Seyedmehrad Tavallai; Sophonie Jean; Abigail Fidanza; Tanya Cruz-Luna; Paul Siembiba; Kelly A Cycon; Cynthia N Cornelissen; Paul Dent
Journal:  J Cell Physiol       Date:  2015-07       Impact factor: 6.384

3.  Epigallocatechin-3-Gallate (EGCG) Inhibits SARS-CoV-2 Infection in Primate Epithelial Cells: (A Short Communication).

Authors:  Brett L Hurst; Douglas Dickinson; Stephen Hsu
Journal:  Microbiol Infect Dis       Date:  2021

4.  Pathophysiology of Ebola Virus Infection: Current Challenges and Future Hopes.

Authors:  Andrea Rivera; Ilhem Messaoudi
Journal:  ACS Infect Dis       Date:  2015-03-30       Impact factor: 5.084

5.  The PERK Arm of the Unfolded Protein Response Negatively Regulates Transmissible Gastroenteritis Virus Replication by Suppressing Protein Translation and Promoting Type I Interferon Production.

Authors:  Mei Xue; Fang Fu; Yanlong Ma; Xin Zhang; Liang Li; Li Feng; Pinghuang Liu
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

6.  AR-12 Inhibits Multiple Chaperones Concomitant With Stimulating Autophagosome Formation Collectively Preventing Virus Replication.

Authors:  Laurence Booth; Jane L Roberts; Heath Ecroyd; Sarah R Tritsch; Sina Bavari; St Patrick Reid; Stefan Proniuk; Alexander Zukiwski; Abraham Jacob; Claudia S Sepúlveda; Federico Giovannoni; Cybele C García; Elsa Damonte; Javier González-Gallego; María J Tuñón; Paul Dent
Journal:  J Cell Physiol       Date:  2016-06-06       Impact factor: 6.384

Review 7.  Potential protective mechanisms of green tea polyphenol EGCG against COVID-19.

Authors:  Zhichao Zhang; Xiangchun Zhang; Keyi Bi; Yufeng He; Wangjun Yan; Chung S Yang; Jinsong Zhang
Journal:  Trends Food Sci Technol       Date:  2021-05-25       Impact factor: 16.002

8.  The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection.

Authors:  Anthony J Carlos; Dat P Ha; Da-Wei Yeh; Richard Van Krieken; Chun-Chih Tseng; Pu Zhang; Parkash Gill; Keigo Machida; Amy S Lee
Journal:  J Biol Chem       Date:  2021-05-06       Impact factor: 5.157

9.  OSU-03012 and Viagra Treatment Inhibits the Activity of Multiple Chaperone Proteins and Disrupts the Blood-Brain Barrier: Implications for Anti-Cancer Therapies.

Authors:  Laurence Booth; Jane L Roberts; Mehrad Tavallai; Aida Nourbakhsh; John Chuckalovcak; Jori Carter; Andrew Poklepovic; Paul Dent
Journal:  J Cell Physiol       Date:  2015-08       Impact factor: 6.384

10.  Is There any Alternative Receptor for SARS-CoV-2?

Authors:  Mahtab Shahriari Felordi; Arash Memarnejadian; Mustapha Najimi; Massoud Vosough
Journal:  Cell J       Date:  2021-05-26       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.